Clinical Trials Insight: 700036011

Trial Profile

Clinical Trials Insight: 700036011

Phase of Trial: Phase II

Latest Information Update: 13 Oct 2008

At a glance

  • Drugs Olanzapine; Zonisamide/olanzapine
  • Indications Schizophrenia
  • Focus Adverse reactions
  • Sponsors Orexigen Therapeutics
  • Most Recent Events

    • 13 Oct 2008 Status changed from planning to recruiting.
    • 07 Aug 2008 New trial record.
Restricted Access

Oops, it looks like you don’t have a valid subscription to this content. To gain full access to the content and functionality of the AdisInsight database try one of the following.

  • with a username/password associated to an account with a valid subscription
  • Contact your organization’s admin about adding this content to your AdisInsight subscription
  • Request a trial

If you are a subscriber to this content then contact us at so we can help.

Back to top